Investor Presentation Full Year 2017
Investor Presentation
Full year 2017
Slide 47
Maintaining global insulin leadership by sustaining modern
and new-generation insulin market share
Novo Nordisk global volume market share across insulin classes
tMU
500
Human insulin¹
100%
tMU
500
Modern and new-
generation insulin
volume
tMU
Novo Nordisk market share (%)
100% 500
Total insulin
100%
400
Market value²:
DKK 24 billion
80%
400
Market value²:
DKK 223 billion
Market value²:
80%
400
80%
DKK 248 billion
300
60% 300
60%
300
60%
200
100
40% 200
40%
200
40%
20% 100
- 20%
100
20%
0
Nov
2012
0%
0%
0
0%
Nov
Nov
Nov
Nov
Nov
2017
2012
2017
2012
2017
1 Includes animal insulin. 2 Annual value of total insulin class. tMU: Thousand mega units
Note: Data is sensitive to changes in IQVIA data collection and reporting methodology
Source: IQVIA (formerly IMS) monthly MAT Nov, 2017 value and volume figures
changing
diabetes®
novo nordiskView entire presentation